In the News

STAT: Lawmaker asks HHS to ensure Gilead’s remdesivir is affordable if U.S. taxpayers funded R&D
May 1, 2020
In The News

By Ed Silverman

https://www.statnews.com/pharmalot/2020/05/01/gilead-remdesivir-coronavirus-cov…
Now that preliminary trial results indicate an experimental Gilead Sciences (GILD) drug can successfully treat some Covid-19, one lawmaker wants to know if U.S. taxpayer dollars helped pay for any of the research and development and, if so, what the federal government will do to ensure that Americans do not later encounter “price gouging.”
Issues:Coronavirus (COVID-19)
Bloomberg: HEALTH CARE BRIEFING
April 30, 2020
In The News

By Brandon Lee

https://about.bgov.com/news/health-care-briefing-gilead-virus-drug-stirs-cautio…

Serological Testing Probe: Yesterday, House Ways and Means Health Subcommittee Chairman Lloyd Doggett (D-Texas) called on the FDA to "swiftly end" the "current ‘free-for-all' policy" on serological tests, demanding the agency "immediately require validation data" to help remove tests from the U.S.

Trump1
Austin American-Statesman Oped: Doggett, Whitehouse: Corrupt tax provision in CARES Act needs to be fixed
April 23, 2020
In The News

By U.S. Rep. Lloyd Doggett and U.S. Sen. Sheldon Whitehouse

https://www.statesman.com/opinion/20200423/doggett-whitehouse-corrupt-tax-provi…
As Americans battled the human and economic devastation of COVID-19, Congress sent rapid relief out to families, our health sector, small businesses and our economy. The CARES Act enjoyed wide bipartisan support and will help if implemented effectively. But tucked into its 880 pages were Republican-inserted tax provisions. The more we’ve learned about their immense cost and the few that they benefit, the clearer it is that they have to go.
Issues:Coronavirus (COVID-19)
Washington Post: CDC director warns second wave of coronavirus is likely to be even more devastating
April 21, 2020
In The News

By Lena H. Sun

https://www.washingtonpost.com/health/2020/04/21/coronavirus-secondwave-cdcdire…
Even as states move ahead with plans to reopen their economies, the director of the Centers for Disease Control and Prevention warned Tuesday that a second wave of the novel coronavirus will be far more dire because it is likely to coincide with the start of flu season.
Issues:Coronavirus (COVID-19)
WAPO
The Washington Post: U.S. sent millions of face masks to China early this year, ignoring pandemic warning signs
April 18, 2020
In The News

By Juliet Eilperin, Jeff Stein, Desmond Butler and Tom Hamburger

https://www.washingtonpost.com/health/us-sent-millions-of-face-masks-to-china-e…
In those two months, the value of protective masks and related items exported from the United States to China grew more than 1,000 percent compared with the same time last year — from $1.4 million to about $17.6 million, according to a Post analysis of customs categories which, according to research by Public Citizen, contain key personal protective equipment (PPE). Similarly, shipments of ventilators and protective garments jumped by triple digits.
Issues:Coronavirus (COVID-19)
Trump11
The Financial Times: The US is failing the test of the century
April 16, 2020
In The News

By Edward Luce

https://www.ft.com/content/2536e0c9-f268-456c-9afa-668f7a377340
Like an asteroid, coronavirus is the textbook example of an exogenous shock. The threat came from beyond. Yet the pathogen offers a unique stress test of each country’s resilience. Some nation states are holding up well. In spite of its unmatched scientific resources, the US is not. More worrying, it is showing little sign of lifting its performance. Six weeks after its first coronavirus death, America’s learning curve remains flatter than its infection rate. It should be the other way round.
Issues:Coronavirus (COVID-19)
Politico: Adapting cancer research to coronavirus
April 10, 2020
In The News

By SARAH OWERMOHLE

https://www.politico.com/newsletters/prescription-pulse/2020/04/10/adapting-can…

— NCI tries to adapt cancer trials to the "all hands on deck" outbreak.

— N-95 mask production is stalling amid a government bottleneck.

— New Jersey is scouring for meds as shortages worsen and case numbers climb.

Politico: Get that money out the door
April 10, 2020
In The News
https://www.politico.com/newsletters/morning-tax/2020/04/10/get-that-money-out-…

Editor's Note: Morning Tax is a free version of POLITICO Pro Tax morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day's biggest stories.

Wall Street Journal: Testing for Coronavirus: What We Know About Covid-19 Tests and Treatment
April 10, 2020
In The News

By Thomas M. Burton and WSJ Staff

https://www.wsj.com/articles/who-has-covid-19-what-we-know-about-tests-for-the-…
As the U.S. quickly builds its capacity to test people for the new coronavirus, some researchers believe that as many as one in three infected people get inaccurate results, raising the chance they may infect others.
The New York Times: Here’s What the Relief Packages Give Self-Employed Workers
April 10, 2020
In The News

By Tara Siegel Bernard

The NY Times: Here’s What the Relief Packages Give Self-Employed Workers
Tax credits for sick leave, expanded unemployment insurance, tax changes and more.
Issues:Coronavirus (COVID-19)
Austin District Office
300 East 8th St, 7th Floor
Austin, TX  78701
Phone: (512) 916-5921
Washington DC Office
2307 Rayburn House Office Building
Washington, DC  20515
Phone: (202) 225-4865